ClinicalTrials.Veeva

Menu
E

Evolution Research Group | Woodland Research Northwest

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

SEP-363856
Edaravone
Rapastinel
Cariprazine
Brexpiprazole
Glucose
JNJ-42847922
Risperidone
Rimegepant
Roluperidone

Parent organization

This site is a part of Evolution Research Group

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 57 total trials

A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's Disease

This is a 17-week double-blind, placebo-controlled, randomized, flexible-dosing, parallel-group, multicenter study designed to evaluate the efficacy...

Enrolling
Tremor
Parkinson Disease
Drug: Suvecaltamide
Drug: Placebo

This is a 12-week, double-blind, placebo-controlled, randomized, parallel-group, multicenter study of the safety and efficacy of JZP385 in the treatm...

Active, not recruiting
Essential Tremor
Drug: JZP385
Other: Placebo

This is a Phase 3, multicenter, 56-week, outpatient, open-label (OL) study to evaluate the long-term safety, tolerability, and efficacy of KarXT in d...

Active, not recruiting
Schizophrenia
Drug: Xanomeline and Trospium Chloride Capsules

This is a Phase 2 study randomized, quadruple masked, multi-center study designed to investigate the efficacy and safety of a single dose of BPL-003...

Enrolling
Treatment Resistant Depression
Drug: BPL-003

The purpose of the study is to evaluate changes in biomarkers of exposure (BoE) to harmful and potentially harmful constituents (HPHCs) in adult smok...

Enrolling
Tobacco Use
Other: Ploom HTP Menthol HTS; MX3 (681)
Other: Ploom HTP Tobacco HTS; R8 (120)

The ENCALM trial is designed to evaluate the efficacy and safety of ENX-102 in patients diagnosed with generalized anxiety disorder (GAD)

Enrolling
Generalized Anxiety Disorder
Drug: Placebo
Drug: ENX-102

This is a Phase 2, randomized, double-blind, placebo-controlled, multi-center inpatient study to evaluate the efficacy and safety of LB-102 in adult...

Enrolling
Schizophrenia
Drug: LB-102

Trial sponsors

Otsuka logo
AbbVie logo
Allergan logo
Jazz Pharmaceuticals logo
Mitsubishi Tanabe Pharma logo
Janssen (J&J Innovative Medicine) logo
R
Pfizer logo
R
Roche logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems